bci

Bill Ackman's $42.5M bet on less invasive brain implants signals capital's turn away from single-neuron precision toward infection risk reduction and faster FDA approval paths.

Epia Neuro's integration of a motorized glove with its brain-computer interface for stroke recovery positions it in a growing neurotech market, raising questions about scalability and long-term profitability amidst intense competition and complex reimbursement landscapes.